Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 11 | 613215 | missense variant | A/C | snv |
|
0.800 | 0 | |||||||||||||
|
0.851 | 0.160 | 11 | 613208 | missense variant | T/C | snv | 0.25 | 0.33 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.720 | 0.667 | 3 | 2011 | 2017 | ||||||
|
0.882 | 0.160 | 11 | 614318 | missense variant | T/C | snv | 0.25 | 0.33 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
|
1.000 | 0.080 | 11 | 617228 | 3 prime UTR variant | G/A | snv | 0.33 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 11 | 613094 | stop gained | G/A | snv | 4.0E-06 | 1.4E-05 |
|
0.700 | 0 | |||||||||||
|
1.000 | 11 | 612797 | missense variant | C/T | snv | 4.1E-06 | 7.0E-06 |
|
0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.851 | 0.200 | 11 | 614864 | synonymous variant | C/T | snv | 0.83 | 0.85 |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.851 | 0.200 | 11 | 614864 | synonymous variant | C/T | snv | 0.83 | 0.85 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.851 | 0.200 | 11 | 614864 | synonymous variant | C/T | snv | 0.83 | 0.85 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.851 | 0.200 | 11 | 614864 | synonymous variant | C/T | snv | 0.83 | 0.85 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.882 | 0.160 | 11 | 614318 | missense variant | T/C | snv | 0.25 | 0.33 |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.882 | 0.160 | 11 | 614318 | missense variant | T/C | snv | 0.25 | 0.33 |
|
0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.080 | 11 | 616031 | upstream gene variant | T/C | snv | 4.5E-02 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.040 | 11 | 612967 | intron variant | A/G | snv | 0.25 | 0.33 |
|
Infections | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||
|
0.851 | 0.160 | 11 | 613208 | missense variant | T/C | snv | 0.25 | 0.33 |
|
0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.160 | 11 | 613208 | missense variant | T/C | snv | 0.25 | 0.33 |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.851 | 0.160 | 11 | 613208 | missense variant | T/C | snv | 0.25 | 0.33 |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
11 | 612721 | missense variant | C/T | snv | 7.0E-06 |
|
Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.882 | 0.240 | 11 | 616865 | 3 prime UTR variant | G/A | snv | 5.8E-02 | 4.7E-02 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Infections; Nervous System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.882 | 0.240 | 11 | 616865 | 3 prime UTR variant | G/A | snv | 5.8E-02 | 4.7E-02 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.882 | 0.240 | 11 | 616865 | 3 prime UTR variant | G/A | snv | 5.8E-02 | 4.7E-02 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 |